Bulletin from the extraordinary general meeting of D. Carnegie & Co AB

The extraordinary general meeting of D. Carnegie & Co AB (publ) (the ”Company”) held on 23 March 2016 passed the following resolutions: 

Resolution regarding authorization for the board of directors to resolve to issue new shares of series B
The extraordinary general meeting of the Company today resolved, in accordance with the proposal from the board of directors, to authorize the board of directors for the period up to the next annual general meeting to, whether on one or several occasions, against cash payment, or otherwise on special conditions, resolve to issue: a) new shares of series B without preferential rights for the shareholders; provided however that such issue of shares must never result in the Company’s issued share capital or the number of shares of series B in the Company at any time, being increased by more than a total of 10 per cent; and, b) new shares of series B with preferential rights for the shareholders, provided however that such issue of shares must never result in that the number of shares of series B in the Company at any time, being increased by more than 10,000,000 new shares or that any such issue result in the Company’s share capital exceeding the Company’s maximum allowed share capital as set out in the articles of association.

The Company has appointed SEB and ABG Sundal Collier as advisors for a planned share issue on the basis of the authorization.

For more information, please contact:
Ulf Nilsson, CEO, D. Carnegie & Co

+46 (0)8 – 121 317 25

Knut Pousette, Chairman of the board of directors, D. Carnegie & Co

+46 (0)8 – 121 317 00

This information is such information that D. Carnegie & Co AB (publ) is required to disclose pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instrument Trading Act. The information was released for publication on 23 March 2016 at [●] [a.m./p.m.] (CET).

Tags: